Valuation: Sartorius AG

Market Cap 14.59B 16.85B 13.63B 12.46B 23.48B 1,607B 23.85B 160B 62.73B 804B 63.27B 61.89B 2,677B P/E 2026 *
62.3x
P/E 2027 * 47.3x
Enterprise Value 18.15B 20.97B 16.97B 15.51B 29.22B 2,000B 29.68B 199B 78.07B 1,000B 78.74B 77.02B 3,332B EV / Sales 2026 *
4.87x
EV / Sales 2027 * 4.37x
Free-Float
35.87%
Yield 2026 *
0.34%
Yield 2027 * 0.42%
1 day+5.11%
Current month+5.11%
1 month+5.48%
3 months+7.26%
6 months-0.06%
Current year+0.57%
1 month 256.25
Extreme 256.25
274.3
Current year 233.92
Extreme 233.92
312.93
1 year 221.24
Extreme 221.24
312.93
3 years 198.85
Extreme 198.8499
423.7
5 years 198.85
Extreme 198.8499
736.22
10 years 74.75
Extreme 74.75
736.22
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2025
Director of Finance/CFO 55 01/04/2024
Chief Operating Officer 70 01/01/2001
Director TitleAgeSince
Director/Board Member 71 01/01/2020
Director/Board Member 77 29/11/2011
Director/Board Member 60 06/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+5.11%0.00% - - 16.86B
+2.76%+5.95%+29.99%-35.16% 16.86B
-5.20%-6.41%-11.81%+87.34% 1.75B
0.00%+2.96%-27.16%+24.78% 1.01B
+7.65%-28.01%-46.07%-83.53% 842M
+0.44%+4.09%-36.69%-50.71% 679M
+2.62%+3.49%-46.78%-49.14% 548M
+48.71%+54.57%+88.59%-15.05% 523M
-1.03%+5.34%-45.11%-42.16% 417M
0.00%+2.97%-7.75%-23.99% 384M
Average +5.81%+0.32%-11.42%-20.85% 2.56B
Weighted average by Cap. +3.85%+3.80%+17.07%-25.26%

Financials

2026 *2027 *
Net sales 3.72B 4.3B 3.48B 3.18B 6B 410B 6.09B 40.83B 16.02B 205B 16.16B 15.8B 684B 4.08B 4.72B 3.82B 3.49B 6.57B 450B 6.67B 44.74B 17.56B 225B 17.71B 17.32B 749B
Net income 249M 288M 233M 213M 401M 27.43B 407M 2.73B 1.07B 13.72B 1.08B 1.06B 45.71B 328M 379M 306M 280M 527M 36.1B 536M 3.59B 1.41B 18.06B 1.42B 1.39B 60.15B
Net Debt 3.57B 4.12B 3.33B 3.05B 5.74B 393B 5.83B 39.09B 15.34B 197B 15.47B 15.13B 655B 3.26B 3.77B 3.05B 2.79B 5.25B 359B 5.33B 35.74B 14.03B 180B 14.15B 13.84B 599B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
10/08/26 $270.29 +5.11% 230
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
232.20EUR
Average target price
265.95EUR
Spread / Average Target
+14.53%

Quarterly revenue - Rate of surprise